Medicofarma Biotech SA

zł 0.37As of Sun 8 Nov 2026, 12:00 UTC
WSE:MDBHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR (4.71%)
Div yield —
ROE (40.48%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.78
PE TTM —
TSR TTM (32.73%)
Mkt cap zł 25.15M
ROIC (17.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 0.469
26.64%
0.20%
Hold 0|12|3|4|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.01
0.01
0.01
0.01
12.90%
23.96%
18.46%
14.12%
Revenuezł M
2.759
2.882
2.979
3.075
6.03%
9.81%
14.54%
16.68%
Peers (US$6.352M)
Cap (US$)
PE
11.79M
9.105x
7.876M
—
Capital
TTM
5Y
10Y
Leveragex
0.237
0.450
0.391
EBIT/Intx
1.185
0.239
0.229
Own earn%
38.22
26.35
6.59
Sh yield%
28.89
61.40
54.76
Owners
Insiders/Inst%
1.30
82.24
Short interest%
1.69
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
16–22
$1 testx
—
Incr. ROIC%
13